413 related articles for article (PubMed ID: 32698441)
21. The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice.
Bao L; Deng W; Huang B; Gao H; Liu J; Ren L; Wei Q; Yu P; Xu Y; Qi F; Qu Y; Li F; Lv Q; Wang W; Xue J; Gong S; Liu M; Wang G; Wang S; Song Z; Zhao L; Liu P; Zhao L; Ye F; Wang H; Zhou W; Zhu N; Zhen W; Yu H; Zhang X; Guo L; Chen L; Wang C; Wang Y; Wang X; Xiao Y; Sun Q; Liu H; Zhu F; Ma C; Yan L; Yang M; Han J; Xu W; Tan W; Peng X; Jin Q; Wu G; Qin C
Nature; 2020 Jul; 583(7818):830-833. PubMed ID: 32380511
[TBL] [Abstract][Full Text] [Related]
22. J2N-k hamster model simulates severe infection caused by severe acute respiratory syndrome coronavirus 2 in patients with cardiovascular diseases.
Lee H; Lee TY; Jeon P; Kim N; Kim JW; Yang JS; Kim KC; Lee JY
J Virol Methods; 2022 Jan; 299():114306. PubMed ID: 34601000
[TBL] [Abstract][Full Text] [Related]
23. Longitudinal analyses using
Cong Y; Lee JH; Perry DL; Cooper K; Wang H; Dixit S; Liu DX; Feuerstein IM; Solomon J; Bartos C; Seidel J; Hammoud DA; Adams R; Anthony SM; Liang J; Schuko N; Li R; Liu Y; Wang Z; Tarbet EB; Hischak AMW; Hart R; Isic N; Burdette T; Drawbaugh D; Huzella LM; Byrum R; Ragland D; St Claire MC; Wada J; Kurtz JR; Hensley LE; Schmaljohn CS; Holbrook MR; Johnson RF
Antiviral Res; 2023 Jun; 214():105605. PubMed ID: 37068595
[TBL] [Abstract][Full Text] [Related]
24. [An electron microscopic study of neocortex of Syrian hamsters (
Paramonova NM; Chepur SV; Pervak MО; Myasnikov VA; Tyunin MA; Ilinskiy NS; Kanevskij BA; Smirnova AV
Vopr Virusol; 2022 Nov; 67(5):403-413. PubMed ID: 36515286
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of a panel of therapeutic antibody clinical candidates for efficacy against SARS-CoV-2 in Syrian hamsters.
Cong Y; Mucker EM; Perry DL; Dixit S; Kollins E; Byrum R; Huzella L; Kim R; Josleyn M; Kwilas S; Stefan C; Shoemaker CJ; Koehler J; Coyne S; Delp K; Liang J; Drawbaugh D; Hischak A; Hart R; Postnikova E; Vaughan N; Asher J; St Claire M; Hanson J; Schmaljohn C; Eakin AE; Hooper JW; Holbrook MR
Antiviral Res; 2023 May; 213():105589. PubMed ID: 37003305
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the pathogenesis of SARS-CoV-2 infection in K18-hACE2 mouse and Syrian golden hamster models.
Jeong H; Woo Lee Y; Park IH; Noh H; Kim SH; Kim J; Jeon D; Jang HJ; Oh J; On D; Uhm C; Cho K; Oh H; Yoon S; Seo JS; Kim JJ; Seok SH; Lee YJ; Hong SM; An SH; Yeon Kim S; Kim YB; Hwang JY; Lee HJ; Kim HB; Jeong DG; Song D; Song M; Park MS; Choi KS; Park JW; Seo JY; Yun JW; Shin JS; Lee HY; Nam KT; Seong JK
Dis Model Mech; 2022 Nov; 15(11):. PubMed ID: 36222118
[TBL] [Abstract][Full Text] [Related]
27. Pathogenic and transcriptomic differences of emerging SARS-CoV-2 variants in the Syrian golden hamster model.
O'Donnell KL; Pinski AN; Clancy CS; Gourdine T; Shifflett K; Fletcher P; Messaoudi I; Marzi A
EBioMedicine; 2021 Nov; 73():103675. PubMed ID: 34758415
[TBL] [Abstract][Full Text] [Related]
28. Co-administration of Favipiravir and the Remdesivir Metabolite GS-441524 Effectively Reduces SARS-CoV-2 Replication in the Lungs of the Syrian Hamster Model.
Chiba S; Kiso M; Nakajima N; Iida S; Maemura T; Kuroda M; Sato Y; Ito M; Okuda M; Yamada S; Iwatsuki-Horimoto K; Watanabe T; Imai M; Armbrust T; Baric RS; Halfmann PJ; Suzuki T; Kawaoka Y
mBio; 2021 Feb; 13(1):e0304421. PubMed ID: 35100870
[TBL] [Abstract][Full Text] [Related]
29. Progression and Resolution of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Golden Syrian Hamsters.
Mulka KR; Beck SE; Solis CV; Johanson AL; Queen SE; McCarron ME; Richardson MR; Zhou R; Marinho P; Jedlicka A; Guerrero-Martin S; Shirk EN; Braxton AM; Brockhurst J; Creisher PS; Dhakal S; Brayton CF; Veenhuis RT; Metcalf Pate KA; Karakousis PC; Zahnow CA; Klein SL; Jain SK; Tarwater PM; Pekosz AS; Villano JS; Mankowski JL;
Am J Pathol; 2022 Feb; 192(2):195-207. PubMed ID: 34767812
[TBL] [Abstract][Full Text] [Related]
30. Coinfection by Severe Acute Respiratory Syndrome Coronavirus 2 and Influenza A(H1N1)pdm09 Virus Enhances the Severity of Pneumonia in Golden Syrian Hamsters.
Zhang AJ; Lee AC; Chan JF; Liu F; Li C; Chen Y; Chu H; Lau SY; Wang P; Chan CC; Poon VK; Yuan S; To KK; Chen H; Yuen KY
Clin Infect Dis; 2021 Jun; 72(12):e978-e992. PubMed ID: 33216851
[TBL] [Abstract][Full Text] [Related]
31. Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection.
Rosenke K; Meade-White K; Letko M; Clancy C; Hansen F; Liu Y; Okumura A; Tang-Huau TL; Li R; Saturday G; Feldmann F; Scott D; Wang Z; Munster V; Jarvis MA; Feldmann H
Emerg Microbes Infect; 2020 Dec; 9(1):2673-2684. PubMed ID: 33251966
[TBL] [Abstract][Full Text] [Related]
32. STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters.
Boudewijns R; Thibaut HJ; Kaptein SJF; Li R; Vergote V; Seldeslachts L; Van Weyenbergh J; De Keyzer C; Bervoets L; Sharma S; Liesenborghs L; Ma J; Jansen S; Van Looveren D; Vercruysse T; Wang X; Jochmans D; Martens E; Roose K; De Vlieger D; Schepens B; Van Buyten T; Jacobs S; Liu Y; Martí-Carreras J; Vanmechelen B; Wawina-Bokalanga T; Delang L; Rocha-Pereira J; Coelmont L; Chiu W; Leyssen P; Heylen E; Schols D; Wang L; Close L; Matthijnssens J; Van Ranst M; Compernolle V; Schramm G; Van Laere K; Saelens X; Callewaert N; Opdenakker G; Maes P; Weynand B; Cawthorne C; Vande Velde G; Wang Z; Neyts J; Dallmeier K
Nat Commun; 2020 Nov; 11(1):5838. PubMed ID: 33203860
[TBL] [Abstract][Full Text] [Related]
33. Cytokine response and damages in the lungs of aging Syrian hamsters on a high-fat diet infected with the SARS-CoV-2 virus.
Fomin G; Tabynov K; Islamov R; Turebekov N; Yessimseit D; Yerubaev T
Front Immunol; 2023; 14():1223086. PubMed ID: 37520568
[TBL] [Abstract][Full Text] [Related]
34. Host Response of Syrian Hamster to SARS-CoV-2 Infection including Differences with Humans and between Sexes.
Castellan M; Zamperin G; Franzoni G; Foiani G; Zorzan M; Drzewnioková P; Mancin M; Brian I; Bortolami A; Pagliari M; Oggiano A; Vascellari M; Panzarin V; Crovella S; Monne I; Terregino C; De Benedictis P; Leopardi S
Viruses; 2023 Feb; 15(2):. PubMed ID: 36851642
[TBL] [Abstract][Full Text] [Related]
35. Neutralizing Monoclonal Antibodies That Target the Spike Receptor Binding Domain Confer Fc Receptor-Independent Protection against SARS-CoV-2 Infection in Syrian Hamsters.
Su W; Sia SF; Schmitz AJ; Bricker TL; Starr TN; Greaney AJ; Turner JS; Mohammed BM; Liu Z; Choy KT; Darling TL; Joshi A; Cheng KM; Wong AYL; Harastani HH; Nicholls JM; Whelan SPJ; Bloom JD; Yen HL; Ellebedy AH; Boon ACM
mBio; 2021 Oct; 12(5):e0239521. PubMed ID: 34517754
[TBL] [Abstract][Full Text] [Related]
36. Oral SARS-CoV-2 Inoculation Establishes Subclinical Respiratory Infection with Virus Shedding in Golden Syrian Hamsters.
Lee AC; Zhang AJ; Chan JF; Li C; Fan Z; Liu F; Chen Y; Liang R; Sridhar S; Cai JP; Poon VK; Chan CC; To KK; Yuan S; Zhou J; Chu H; Yuen KY
Cell Rep Med; 2020 Oct; 1(7):100121. PubMed ID: 32984855
[TBL] [Abstract][Full Text] [Related]
37. Hamsters Expressing Human Angiotensin-Converting Enzyme 2 Develop Severe Disease following Exposure to SARS-CoV-2.
Golden JW; Li R; Cline CR; Zeng X; Mucker EM; Fuentes-Lao AJ; Spik KW; Williams JA; Twenhafel N; Davis N; Moore JL; Stevens S; Blue E; Garrison AR; Larson DD; Stewart R; Kunzler M; Liu Y; Wang Z; Hooper JW
mBio; 2022 Feb; 13(1):e0290621. PubMed ID: 35073750
[TBL] [Abstract][Full Text] [Related]
38. ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques.
van Doremalen N; Lambe T; Spencer A; Belij-Rammerstorfer S; Purushotham JN; Port JR; Avanzato VA; Bushmaker T; Flaxman A; Ulaszewska M; Feldmann F; Allen ER; Sharpe H; Schulz J; Holbrook M; Okumura A; Meade-White K; Pérez-Pérez L; Edwards NJ; Wright D; Bissett C; Gilbride C; Williamson BN; Rosenke R; Long D; Ishwarbhai A; Kailath R; Rose L; Morris S; Powers C; Lovaglio J; Hanley PW; Scott D; Saturday G; de Wit E; Gilbert SC; Munster VJ
Nature; 2020 Oct; 586(7830):578-582. PubMed ID: 32731258
[TBL] [Abstract][Full Text] [Related]
39. A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures.
Dinnon KH; Leist SR; Schäfer A; Edwards CE; Martinez DR; Montgomery SA; West A; Yount BL; Hou YJ; Adams LE; Gully KL; Brown AJ; Huang E; Bryant MD; Choong IC; Glenn JS; Gralinski LE; Sheahan TP; Baric RS
Nature; 2020 Oct; 586(7830):560-566. PubMed ID: 32854108
[TBL] [Abstract][Full Text] [Related]
40. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
